Please assess the completion status of the following clinical trial:

Trial Title: Abdominal Colpopexy: Comparison of Endoscopic Surgical Strategies

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Stage II to IV pelvic organ prolapse~2. Prolapse of the vaginal apex or cervix to at least half way into the vaginal canal~3. Vaginal bulge symptoms~4. Minimally invasive surgery is planned~5. Available for 12 months of follow-up~6. Able to complete study assessments~7. Able and willing to provide written informed consent~Exclusion Criteria:~1. Contraindication to laparoscopic or robotically assisted laparoscopic abdominal sacrocolpopexy~2. Subject wishes to retain her uterus (i.e., surgical assignment may involve removal of uterus, if not previously removed)

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Laparoscopic Abdominal Sacrocolpopexy (LASC) (Type: ACTIVE_COMPARATOR): Women assigned to this cohort will receive standard laparoscopic abdominal sacrocolpopexy (LASC)
- Robotic Assisted Laparoscopic (RASC) (Type: EXPERIMENTAL): Women assigned to this cohort will receive robotic assisted laparoscopic abdominal sacrocolpopexy (RASC)

Based on this trial design, predict the completion outcome and termination type (if applicable).